Princeton-based Calyptus Pharmaceuticals Inc. announced Aug. 22 that it entered into an agreement with Provepharm SAS to accelerate development of its complex injectable product used in acute care ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback